Medicare Enrolled
Dr. Mark Fishel, MD
Neurology · Bellevue, WA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Fishel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fishel?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Fishel
Dr. Mark Fishel is a neurology specialist in Bellevue, WA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Fishel performed 197 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Fishel received a total of $21,666 from 86 pharmaceutical and/or device companies across 1116 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Fishel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ 197 Medicare services
$21,666 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗197
Medicare services
Bottom 31% in WA for neurology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$104
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
152 | $88 | $300 |
| New patient office visit, complex (60-74 min) | 24 | $174 | $500 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
21 | $138 | $400 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$21,666
Total received (2018-2024)
Avg $3,095/year across 7 years
Top 12% in WA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
86
Companies
1,116
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,004
2023
$2,175
2022
$2,777
2021
$2,289
2020
$2,512
2019
$3,769
2018
$4,139
Payments by company (2024)
ABBVIE INC.
$356
Lilly USA, LLC
$351
Teva Pharmaceuticals USA, Inc.
$336
Eisai Inc.
$322
Novartis Pharmaceuticals Corporation
$300
Biogen, Inc.
$287
ACADIA Pharmaceuticals Inc
$196
Neurelis, Inc.
$162
EMD Serono, Inc.
$152
Otsuka America Pharmaceutical, Inc.
$146
Celgene Corporation
$136
UCB, Inc.
$136
PFIZER INC.
$112
Lundbeck LLC
$111
Amneal Pharmaceuticals LLC
$110
CSL Behring
$87
Merz Pharmaceuticals, LLC
$81
Takeda Pharmaceuticals U.S.A., Inc.
$80
IRONSHORE PHARMACEUTICALS INC.
$74
SK Life Science, Inc.
$66
Acorda Therapeutics, Inc
$62
ANI Pharmaceuticals, Inc.
$61
TerSera Therapeutics LLC
$55
Ipsen Biopharmaceuticals, Inc
$51
Neurocrine Biosciences, Inc.
$23
Sumitomo Pharma America, Inc.
$22
Azurity Pharmaceuticals, Inc.
$22
ITF Therapeutics LLC
$21
Amylyx Pharmaceuticals, Inc.
$21
Kedrion Biopharma, Inc.
$20
Genentech USA, Inc.
$17
Cala Health, Inc.
$15
Janssen Scientific Affairs, LLC
$15
Top 3 companies account for 26.0% of 2024 payments
All-time payments by company (2018-2024) ›
Teva Pharmaceuticals USA, Inc.
$1,855
LivaNova USA, Inc.
$1,672
Lilly USA, LLC
$1,150
GE HEALTHCARE
$1,058
Biogen, Inc.
$1,033
ABBVIE INC.
$1,000
Novartis Pharmaceuticals Corporation
$921
EMD Serono, Inc.
$853
ACADIA Pharmaceuticals Inc
$768
Sunovion Pharmaceuticals Inc.
$731
Amgen Inc.
$689
Supernus Pharmaceuticals, Inc.
$670
Lundbeck LLC
$624
UCB, Inc.
$581
Amneal Pharmaceuticals LLC
$568
Upsher-Smith Laboratories LLC
$474
Neurelis, Inc.
$459
Eisai Inc.
$399
Acorda Therapeutics, Inc
$391
Celgene Corporation
$354
GENZYME CORPORATION
$330
IMPEL PHARMACEUTICALS INC.
$314
AbbVie Inc.
$237
Bausch Health US, LLC
$217
Otsuka America Pharmaceutical, Inc.
$205
Avanir Pharmaceuticals, Inc.
$202
SK Life Science, Inc.
$202
Takeda Pharmaceuticals U.S.A., Inc.
$196
ASSERTIO THERAPEUTICS, Inc.
$181
Assertio Therapeutics, Inc.
$181
UPSHER-SMITH LABORATORIES LLC
$163
CSL Behring
$157
Sumitomo Pharma America, Inc.
$156
ARBOR PHARMACEUTICALS, INC.
$155
Allergan, Inc.
$148
Alexion Pharmaceuticals, Inc.
$144
PFIZER INC.
$123
Neurocrine Biosciences, Inc.
$107
Avion Pharmaceuticals
$107
Amylyx Pharmaceuticals, Inc.
$98
Allergan Inc.
$85
Janssen Pharmaceuticals, Inc
$84
Merz Pharmaceuticals, LLC
$81
Grifols USA, LLC
$81
Greenwich Biosciences, Inc.
$81
Alfasigma USA, Inc.
$80
Mylan Pharmaceuticals Inc.
$79
IRONSHORE PHARMACEUTICALS INC.
$74
CATALYST PHARMACEUTICALS, INC.
$61
ANI Pharmaceuticals, Inc.
$61
Promius Pharma LLC
$60
Kyowa Kirin, Inc.
$58
TerSera Therapeutics LLC
$55
US WorldMeds, LLC
$53
Biohaven Pharmaceuticals, Inc.
$53
Akcea Therapeutics, Inc.
$52
Arbor Pharmaceuticals, Inc.
$51
Ipsen Biopharmaceuticals, Inc
$51
Azurity Pharmaceuticals, Inc.
$43
Catalyst Pharmaceuticals, Inc.
$43
Biohaven Pharmaceutical Holding Company Ltd.
$41
GE HealthCare
$32
JAZZ PHARMACEUTICALS INC.
$29
Mitsubishi Tanabe Pharma America, Inc.
$28
Vapotherm Inc
$28
E.R. Squibb & Sons, L.L.C.
$25
Vertical Pharmaceuticals, LLC
$23
Jazz Pharmaceuticals Inc.
$23
ITF Therapeutics LLC
$21
Kedrion Biopharma, Inc.
$20
Saol Therapeutics Inc.
$19
Boston Scientific Corporation
$18
Axsome Therapeutics, Inc.
$17
Genentech USA, Inc.
$17
Impax Laboratories, Inc.
$17
Medtronic USA, Inc.
$17
Adamas Pharmaceuticals, Inc.
$16
Nevro Corp.
$16
Cala Health, Inc.
$15
Janssen Scientific Affairs, LLC
$15
Strongbridge US INC.
$14
Tris Pharma Inc
$14
Egalet US Inc
$12
Zogenix Inc.
$11
Mallinckrodt LLC
$11
Zyla Life Sciences
$11
Top 3 companies account for 21.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Albuked · Austedo XR · BOTOX · BOTOX THERAPEUTIC · Briviact · CALA KIQ · CAMBIA · COPAXONE · Cambia · DAYBUE · Dhivy · Dyanavel XR · Dysport · EMGALITY · Epidiolex · FIRDAPSE · Fintepla · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · GRALISE · Gamunex-C · Glatiramer Acetate · Gralise · HORIZANT · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · JORNAY PM · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LEMTRADA · LEQEMBI · LUMIZYME · LYRICA · Leqembi · Lioresal (baclofen) · MAYZENT · MIGRANAL · Mavenclad · NORTHERA · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · Nuedexta · ONFI · ONGENTYS · OSMOLEX ER · OXTELLAR XR · Ocrevus Zunovo · Ongentys · PLEGRIDY · PURIFIED CORTROPHIN GEL · Ponvory · Precision Flow · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · Quzyttir · RELYVRIO · REXULTI · RYTARY · Radicava · Rebif · SKYCLARYS · SOLIRIS · SPECTRA WAVEWRITER · SPRIX · SUNOSI · SYNCHROMED · Senza Spinal Cord Stimulation System · Sunosi · TECFIDERA · TEGSEDI · TOPIRAMATE EXTENDED RELEASE CAPSULES · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Tosymra Sumatriptan Nasal Spray · Trintellix · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VUMERITY · VYEPTI · Vimpat · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION · ZEPOSIA · ZIPSOR · ZOMIG · Zembrace · Zembrace SymTouch Sumatriptan Injection · Zilbrysq · Zipsor
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
279
County median income
$122,148
Nearest hospital to ZIP centroid (approximate)
OVERLAKE HOSPITAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Fishel is a clinical cardiology specialist, with moderate Medicare volume, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Fishel experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Fishel performed 152 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Fishel receive payments from pharmaceutical companies?
Yes. Dr. Fishel received a total of $21,666 from 86 companies across 1,116 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fishel's costs compare to other neurologists in Bellevue?
Dr. Fishel's average Medicare payment per service is $104. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fishel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Bellevue
Browse neurologists in Bellevue ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in WA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in WA
Which WA neurologists receive the most from drug and device companies.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
LivaNova USA, Inc. Payments to Doctors
See all physicians who received payments from LivaNova USA, Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology